Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: understanding clinical trial results
about
Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: understanding clinical trial results
description
im August 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 07 August 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2018
@uk
name
Dual targeting of HER2-positiv ...... tanding clinical trial results
@en
Dual targeting of HER2-positiv ...... tanding clinical trial results
@nl
type
label
Dual targeting of HER2-positiv ...... tanding clinical trial results
@en
Dual targeting of HER2-positiv ...... tanding clinical trial results
@nl
prefLabel
Dual targeting of HER2-positiv ...... tanding clinical trial results
@en
Dual targeting of HER2-positiv ...... tanding clinical trial results
@nl
P2860
P356
P1433
P1476
Dual targeting of HER2-positiv ...... tanding clinical trial results
@en
P2093
Atanasio Pandiella
Eitan Amir
P2860
P304
31915-31919
P356
10.18632/ONCOTARGET.25739
P407
P577
2018-08-07T00:00:00Z